Gossamer Bio (GOSS) Total Current Liabilities: 2022-2025
Historic Total Current Liabilities for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $62.1 million.
- Gossamer Bio's Total Current Liabilities rose 21.60% to $62.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.1 million, marking a year-over-year increase of 21.60%. This contributed to the annual value of $45.0 million for FY2024, which is 12.77% down from last year.
- Latest data reveals that Gossamer Bio reported Total Current Liabilities of $62.1 million as of Q3 2025, which was up 15.90% from $53.6 million recorded in Q2 2025.
- Gossamer Bio's 5-year Total Current Liabilities high stood at $62.1 million for Q3 2025, and its period low was $34.6 million during Q1 2022.
- Moreover, its 3-year median value for Total Current Liabilities was $45.2 million (2024), whereas its average is $46.9 million.
- Per our database at Business Quant, Gossamer Bio's Total Current Liabilities fell by 19.62% in 2023 and then spiked by 34.63% in 2025.
- Quarterly analysis of 4 years shows Gossamer Bio's Total Current Liabilities stood at $49.2 million in 2022, then climbed by 4.81% to $51.6 million in 2023, then decreased by 12.77% to $45.0 million in 2024, then grew by 21.60% to $62.1 million in 2025.
- Its Total Current Liabilities was $62.1 million in Q3 2025, compared to $53.6 million in Q2 2025 and $48.2 million in Q1 2025.